Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$10,764,041
+$1,245,070 QoQ
Shares Held
85,199
+24.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#418
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HENNESSY ADVISORS INC holds $74,827,284 across 8 Drug Manufacturers - General names. GILD ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
114,850 | $14,758,225 | |
| 2 | JNJ |
Johnson & Johnson
|
49,300 | $12,520,721 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
85,199 | $10,764,041 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
163,850 | $9,441,037 | |
| 5 | PFE |
Pfizer Inc
|
296,113 | $7,130,401 | |
| 6 | AMGN |
Amgen Inc
|
19,120 | $6,923,734 | |
| 7 | ABBV |
AbbVie Inc.
|
27,300 | $6,869,772 | |
| 8 | GSK |
GSK plc
|
122,460 | $6,419,353 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,764,041 | 85,199 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $9,518,971 | 68,300 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $6,824,344 | 55,600 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $6,515,700 | 58,700 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $6,607,852 | 59,600 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $6,678,180 | 59,600 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $5,338,986 | 57,800 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,022,016 | 59,900 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $4,109,739 | 59,900 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $4,475,575 | 61,100 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,917,307 | 60,700 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $4,811,148 | 64,200 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $5,048,085 | 65,500 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,749,821 | 69,300 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $12,551,270 | 146,200 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $9,315,190 | 151,000 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $9,339,491 | 151,100 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,048,290 | 152,200 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,206,137 | 71,700 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $5,126,990 | 73,400 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $5,130,070 | 74,500 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $4,814,935 | 74,500 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $3,839,334 | 65,900 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $4,410,662 | 69,800 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $5,493,516 | 71,400 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $5,435,052 | 72,700 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||